Prelude Therapeutics, Inc. (PRLD)

2.78 +0.51 (+22.47%) USD  |  NASDAQ  |  Feb 20, 16:00
2.78 0.00 (0.00%) After-Hours: 20:00
More

Prelude Therapeutics EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Immunome, Inc. Upgrade
Incyte Corp. Upgrade
Aclaris Therapeutics, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade